World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
85
Citations
25614
World Ranking
1320
National Ranking
682

Medicine

D-Index
85
Citations
25641
World Ranking
14645
National Ranking
7410

Walter J. Storkus publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Walter J. Storkus sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 367 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Walter J. Storkus D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Walter J. Storkus sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 85 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Walter J. Storkus is affiliated with the University of Pittsburgh in the United States and has an extensive research portfolio in medicine, particularly focusing on immunology and oncology. Their scholarly work spans multiple subfields, including immunology, oncology, molecular biology, pulmonary and respiratory medicine, and surgery.

The primary topics covered in Storkus's research include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T Cell Therapy Research
  • Immune Cell Function and Interaction
  • Cutaneous Melanoma Detection and Management
  • Interferon and Immune Responses
  • Immune Cells in Cancer

Storkus has contributed to a number of recent papers that reflect these interests:

  • "STING Agonists as Cancer Therapeutics," 2021, published in Cancers
  • "Epigenetic modulation of antitumor immunity for improved cancer immunotherapy," 2021, published in Molecular Cancer
  • "STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment," 2021, published in Journal for ImmunoTherapy of Cancer
  • "Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy," 2020, published in Biomedicines
  • "Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma," 2021, published in Journal for ImmunoTherapy of Cancer

Among frequent co-authors associated with Storkus are:

  • John M. Kirkwood
  • J Filderman
  • Lilit Karapetyan
  • Ahmad A. Tarhini
  • Cindy Sander

The scientist's research is frequently published in the following venues:

  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer
  • The Journal of Immunology
  • Frontiers in Immunology
  • Journal of Clinical Oncology

Walter J. Storkus has also authored a book published by Frontiers Media titled "Immunotherapy in Renal Cell Carcinoma" released in 2023.

Best Publications

  • Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

    J I Mayordomo;T Zorina;W J Storkus;L Zitvogel

  • Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

    L. Zitvogel;J. I. Mayordomo;Tjendimin Tjandrawan;A. B. Deleo

  • Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.

    Christina M. Celluzzi;Jose I. Mayordomo;Walter J. Storkus;Michael T. Lotze

  • Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

    C L Nastala;H D Edington;T G McKinney;H Tahara

  • Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes

    Eva U. Wieckowski;Carmen Visus;Marta Szajnik;Miroslaw J. Szczepanski

  • α-Type-1 Polarized Dendritic Cells A Novel Immunization Tool with Optimized CTL-inducing Activity

    Robbie B. Mailliard;Anna Wankowicz-Kalinska;Quan Cai;Amy Wesa

  • NK susceptibility varies inversely with target cell class I HLA antigen expression.

    W J Storkus;D N Howell;R D Salter;J R Dawson

  • Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.

    Robbie B. Mailliard;Young Ik Son;Richard Redlinger;Patrick T. Coates

  • Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

    Hideaki Tahara;Herbert J. Zeh;Walter J. Storkus;Itzhak Pappo

  • Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

    Markus J. Maeurer;Susanne M. Gollin;Dina Martin;William Swaney

  • Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

    Ulrich Keilholz;Jeffrey Weber;James H. Finke;Dmitry I. Gabrilovich

  • Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma

    Tomohide Tatsumi;Lisa S. Kierstead;Elena Ranieri;Elena Ranieri;Loreto Gesualdo

  • STING Agonists as Cancer Therapeutics.

    Afsaneh Amouzegar;Manoj Chelvanambi;Jessica N. Filderman;Walter J. Storkus

  • Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

    H. Tahara;L. Zitvogel;W. J. Storkus;H. J. Zeh

  • Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes

    W. J. Storkus;J. Alexander;John A Payne;J. R. Dawson

  • Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Responses In Vitro: Enhancement by Cotransfection of Genes Encoding the Th1-Biasing Cytokines IL-12 and IFN-α

    Thomas Tüting;Cara C. Wilson;Dina M. Martin;Yvette L. Kasamon

  • Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.

    J I Mayordomo;D J Loftus;H Sakamoto;C M De Cesare

  • Immunopolarization of CD4(+) and CD8(+) T cells to type-1-like is associated with melanocyte loss in human vitiligo

    Anna Wańkowicz-Kalińska;René M J G J van den Wijngaard;Bert J Tigges;Wiete Westerhof

  • Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution.

    Walter J. Storkus;Herbert J. Zeh;Russell D. Salter;Michael T. Lotze

  • Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

    Zong Sheng Guo;Binfeng Lu;Zongbi Guo;Esther Giehl

  • Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

    Xinmei Zhu;Fumihiko Nishimura;Kotaro Sasaki;Mitsugu Fujita

  • Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes.

    Chiara Castelli;Walter J. Storkus;Markus J. Maeurer;Dina M. Martin

Frequent Co-Authors

Michael T. Lotze
Michael T. Lotze University of Pittsburgh
Hideho Okada
Hideho Okada University of California, San Francisco
John M. Kirkwood
John M. Kirkwood University of Pittsburgh
Paul D. Robbins
Paul D. Robbins University of Minnesota
Theresa L. Whiteside
Theresa L. Whiteside University of Pittsburgh
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Hideaki Tahara
Hideaki Tahara University of Tokyo
Simon C. Watkins
Simon C. Watkins University of Pittsburgh
Markus Maeurer
Markus Maeurer Champalimaud Foundation
Pawel Kalinski
Pawel Kalinski Roswell Park Comprehensive Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career in immunology or related health sciences, exploring relevant online nursing programs can be a strategic move. Many professionals begin with foundational training through the best online RN programs for non nurses, which provide essential skills to enter the healthcare field.

Once established as a registered nurse, pursuing an accelerated path such as the accelerated FNP program can help you quickly gain advanced practice competencies. Additionally, for those working as family nurse practitioners, specialized options like the FNP to acute care NP bridge program offer a way to expand expertise and enter acute care settings.

Understanding the financial outlook is also important. According to data on how much do DNPs make, salaries vary widely by location and specialization, influencing career decisions. Combining immunology knowledge with advanced nursing degrees opens diverse pathways and the potential for rewarding roles in healthcare.

Best Scientists Citing Walter J. Storkus

Trending Scientists